logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Martin Fuchs

Medical University of Innsbruck
H指数:38
被引数:7,997

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal cancer according to primary tumor sidedness: a pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

抗EGFR抗体与抗VEGF抗体在BRAFV600E突变型转移性结直肠癌中根据原发肿瘤侧性的初始治疗疗效：一项在mCRC初始治疗中进行的七项临床试验的合并分析（德国AIO研究组）

European Journal of Cancer
IF7.1
2025-11-130
OAAI
Lena Weiss; Sebastian Stintzing; Dominik Paul Modest; Arndt Stahler; Ludwig Fischer von Weikersthal; Anke Reinacher-Schick; Thomas Decker; Victoria Probst; Kathrin Heinrich; Ingo Schwaner; Florian Kaiser; Rudolf Pihusch; Martin Fuchs; Swantje Held; Annabel Alig; Birgit Gruenberger; Gerald Werner Prager; David Tougeron; Julien Taieb; Volker Heinemann
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO

转移性结直肠癌一线治疗中疾病进展的风险，以指导疾病再评估——AIO和GONO对11项试验的分析

Annals of Oncology
IF65.4
2025-08-190
OAAI
M.M. Germani; V. Heinemann; D. Rossini; L. Fischer von Weikersthal; F. Pietrantonio; K. Heinrich; A. Stahler; S. Lonardi; F. Kaiser; T. Decker; L. Salvatore; L. Weiss; F. Morano; M. Fuchs; F. Bergamo; C. Antoniotti; G. Masi; S. Stintzing; P. Frumento; C. Cremolini; D.P. Modest
Impact of preoperative radiotherapy on patient-reported outcomes in rectal cancer

术前放疗对直肠癌患者报告结局的影响

Colorectal Disease
IF2.7
2025-07-100
PRE
Robert Siegel; Nora Tabea Sibert; Clara Breidenbach; Cihan Gani; Philipp Alexander Neumann; Stefan Rolf Benz; Stefan Post; Thomas Seufferlein; Vanessa Kolb; Matthias Behrend; Richard David Blossey; Jörg Bunse; Marc Dahlke; Ricarda Diller; Nikos Emmanouilidis; Thomas J. Ettrich; Jörg Fahlke; Sven Flemming; Björn Freitag; Martin Fuchs; Lars Haeder; Stephan Hollerbach; Jens Höppner; Mia Kim; Christian Klink; Jürgen Knuth; Stefan Koeppen; Jörg Köninger; Ernst Wolfgang Kolbe; Florian Kühn; Shueb Mussa; Robert Oehring; Sebastian Petzoldt; Pompiliu Piso; Christian Prause; Christian Prinz; Christoph Reißfelder; Maren Riechmann; Jörg-Peter Ritz; Jens Rolinger; Robert Rosenberg; Hubert Scheuerlein; Dustin Schilawa; Paul Magnus Schneider; Thilo Schwandner; Marco Siech; Daniel Steinemann; Oliver Stöltzing; Elke von Haeften; Dominik Weihs; Armin Wiegering; Christina Barbara Zielinski; Christoph Kowalski
Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials (MAR, 10.1038/s41375-025-02567-w, 2025)

复发霍奇金淋巴瘤治疗后无进展生存期和总生存期的相关性：德国霍奇金研究小组（GHSG）随机试验的个体患者数据分析（MAR, 10.1038/s41375-025-02567-w, 2025）

LEUKEMIA
IF13.4
2025-03-300
OA
Broeckelmann, P. J.; Mueller, H.; Fuchs, M.; Gillessen, S.; Eichenauer, D. A.; Borchmann, S.; Robertz, A. S.; Behringer, K.; Welters, J.; Ferdinandus, J.; Boell, B.; Tharmaseelan, H.; Yang, X.; Kobe, C.; Eich, H. T.; Baues, C.; Klapper, W.; Borchmann, P.
Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials: LYMPHOMA

复发霍奇金淋巴瘤治疗后无进展生存期与总生存期的相关性：德国霍奇金研究组（GHSG）随机试验的个体患者数据分析：LYMPHOMA

LEUKEMIA
IF13.4
2025-03-241
OA
Broeckelmann, P. J.; Mueller, H.; Fuchs, M.; Gillessen, S.; Eichenauer, D.; Borchmann, S.; Robertz, A. S.; Behringer, K.; Welters, J.; Ferdinandus, J.; Boell, B.; Tharmaseelan, H.; Yang, X.; Kobe, C.; Eich, H. -t.; Baues, C.; Klapper, W.; Borchmann, P.
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024)
ESMO OPEN
IF8.3
2024-10-010
OAAI
Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V.
Evaluation of risk of disease progression in first-line therapy of unresected metastatic colorectal cancer to guide intervals of radiological assessment: An analysis of eleven randomized trials by AIO and GONO

评估不可切除的转移性结直肠癌一线治疗中疾病进展风险的评估，以指导放射学评估的间隔：AIO和GONO进行的十一项随机试验的分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Germani, M. M.; Heinemann, V.; Rossini, D.; von Weikersthal, L. Fischer; Morano, F.; Heinrich, K.; Stahler, A.; Bergamo, F.; Kaiser, F.; Decker, T.; Salvatore, L.; Weiss, L.; Russo, A.; Fuchs, M.; Prete, A. A.; Antoniotti, C.; Masi, G.; Stintzing, S.; Cremolini, C.; Modest, D. P.
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024)
ESMO OPEN
IF8.3
2024-05-011
OAAI
Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V.
Practices to support co-design processes: A case-study of co-designing a program for children with parents with a mental health problem in the Austrian region of Tyrol
INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING
IF3.3
2022-10-138
OA
Zechmeister-Koss, Ingrid; Aufhammer, Sandra; Bachler, Herbert; Bauer, Annette; Bechter, Philipp; Buchheim, Anna; Christiansen, Hanna; Fischer, Maria; Franz, Marianne; Fuchs, Martin; Goodyear, Melinda; Gruber, Nadja; Hofer, Alex; Holzle, Laura; Juen, Evi; Papanthimou, Flora; Prokop, Mathias; Paul, Jean Lillian
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314)

FOLFOX加帕尼单抗或FOLFOX单独作为RAS野生型结直肠癌肝转移基本传染数/1切除后的附加疗法-PARLIM试验 (AIO KRK 0314)

EUROPEAN JOURNAL OF CANCER
IF7.1
2022-09-014
PRE
Modest, Dominik Paul; Karthaus, Meinolf; Kasper, Stefan; Moosmann, Nicolas; Keitel, Verena; Kiani, Alexander; Uhlig, Jens; Jacobasch, Lutz; Weikersthal, Ludwig Fischer, V; Fuchs, Martin; Kaiser, Florian; Lerchenmueller, Christian; Sent, Dagmar; Junghanss, Christian; Held, Swantje; Lorenzen, Sylvie; Kaczirek, Klaus; Jung, Andreas; Stintzing, Sebastian; Heinemann, Volker
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)
ESMO OPEN
IF8.3
2022-08-0122
OAAI
Hartlapp, I; Valta-Seufzer, D.; Siveke, J. T.; Algul, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V; Kunzmann, V
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
BMC CANCER
IF3.4
2022-07-277
OAAI
Sommerhaeuser, G.; Kurreck, A.; Stintzing, S.; Heinemann, V; von Weikersthal, L. Fischer; Dechow, T.; Kaiser, F.; Karthaus, M.; Schwaner, I; Fuchs, M.; Koenig, A.; Roderburg, C.; Hoyer, I; Quante, M.; Kiani, A.; Fruehauf, S.; Mueller, L.; Reinacher-Schick, A.; Ettrich, T. J.; Stahler, A.; Modest, D. P.
FIRE-4 (AIO-KRK-0114): Randomized study for a switch maintenance concept with 5-FU plus bevacizumab after induction treatment with FOLFIRI plus cetuximab versus continued treatment with FOLFIRI plus cetuximab - secondary endpoint
ANNALS OF ONCOLOGY
IF65.4
2022-06-010
OA
Heinemann, V.; von Weikersthal, L. Fischer; Fuchs, M.; Kaiser, F.; Heinrich, K.; Modest, D.; Hofheinz, R.; Decker, T.; Gerger, A.; Angermeier, S.; Rumpold, H.; Dickhut, A.; Oehler, L.; Gruenberger, B.; Niedersuess-Beke, D.; Sandmann, M.; Kasper, S.; Prager, G.; Stintzing, S.
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol
FUTURE ONCOLOGY
IF2.6
2022-01-2725
PRE
Ben Khaled, Najib; Seidensticker, Max; Ricke, Jens; Mayerle, Julia; Oehrle, Bettina; Roessler, Daniel; Teupser, Daniel; Ehmer, Ursula; Bitzer, Michael; Waldschmidt, Dirk; Fuchs, Martin; Reuken, Philipp A.; Lange, Christian M.; Wege, Henning; Kandulski, Arne; Dechene, Alexander; Venerito, Marino; Berres, Marie-Luise; Luedde, Tom; Kubisch, Ilja; Reiter, Florian P.; De Toni, Enrico N.

研究方向

暂未获取到该数据
H
Helmut Drexler
H 指数:89论文数:326被引数:3.9万
S
Swantje Held
H 指数:24论文数:181被引数:2,791
F
Frank Kullmann
H 指数:47论文数:343被引数:1.2万
D
Denise Hilfiker‐Kleiner
H 指数:81论文数:331被引数:2.5万
D
Dominik Paul Modest
H 指数:44论文数:436被引数:9,281
T
Thomas J. Ettrich
H 指数:35论文数:300被引数:4,643
S
Stefan Boeck
H 指数:46论文数:265被引数:7,487
L
Ludwig Fischer von Weikersthal
H 指数:41论文数:292被引数:9,604
D
Dirk Waldschmidt
H 指数:25论文数:151被引数:3,755
J
Jens T. Siveke
H 指数:62论文数:743被引数:1.4万